Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition
乳铁蛋白和溶菌酶促进营养、临床和肠道恢复:针对腹泻和营养不良儿童的阶乘安慰剂对照随机试验
基本信息
- 批准号:10095310
- 负责人:
- 金额:$ 67.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdherenceAnemiaAntibiotic ResistanceAntibioticsAreaCampylobacterCaregiversCessation of lifeChildChildhoodChinese PeopleClinicalCold ChainsCombined Modality TherapyConvalescenceDataDehydrationDeteriorationDiarrheaDouble-Blind MethodEnteralEnterobacteriaceaeFailureFamily health statusFunctional disorderFutureGrowthHealthHealth care facilityHealth systemHemoglobinHomeHospitalizationIncidenceInfectionInpatientsInterventionIntestinesIronKenyaLactoferrinLactuloseLength of StayLower Respiratory Tract InfectionMalariaMalnutritionMedicalMicronutrientsMilkMuramidaseNeopterinNutritionalORALITOutcomeOutpatientsParticipantPeroxidasesPeruPeruvianPlacebosPopulationPrevalenceRandomizedRecoveryRecurrenceRehydrationsReportingRhamnoseRiskSafetyShigellaSupplementationTestingTherapeutic InterventionTimeTranslatingUpper armVisitZincadverse outcomeagedantimicrobialcognitive developmentcontrol trialcostcost effective interventioncost effectivenessdiarrheal diseasedietary supplementsdisability-adjusted life yearseffective interventionenteric infectionenteric pathogenenteroaggregative Escherichia coliexperiencehigh riskimprovedimproved outcomelow and middle-income countriesmedical attentionmicronutrient deficiencymortality risknovelpreventrandomized placebo controlled trialrandomized trialstandard of carewasting
项目摘要
PROJECT SUMMARY/ABSTRACT
Diarrhea kills more than half a million children each year and is the third largest contributor to lost disability
adjusted life years. While rehydration addresses the acute consequences of diarrhea, there are no interventions
for diarrhea convalescence during which children are at high risk of malnutrition, lower-respiratory tract
infections, and recurring diarrhea episodes. Safe and effective interventions to address the long-term
consequences of diarrheal disease are urgently needed.
Lactoferrin and lysozyme are milk-derived nutritional supplements that may reduce the duration of diarrheal
episodes, treat or prevent underlying enteric infections, improve enteric function, and accelerate nutritional
recovery. However, it remains unclear whether their antimicrobial action will translate into significant
improvements in the long-term clinical and nutritional outcomes of childhood diarrhea. We propose a factorial,
double-blind, placebo-controlled, randomized trial to determine the efficacy and mechanisms of lactoferrin and
lysozyme supplementation in minimizing the incidence of diarrhea and promoting nutritional recovery among
children recovering from diarrhea and wasting. Kenyan children aged 6-24 months who have been discharged
from an inpatient or outpatient hospital stay for diarrhea, and have a mid-upper arm circumference [MUAC] <12.5
cm will be randomized to 16-weeks of lactoferrin, lysozyme, a combination of the two, or placebo. This trial will
provide much efficacy, mechanistic, and feasibility data from populations most likely to benefit from these
interventions.
项目总结/摘要
腹泻每年导致50多万儿童死亡,是造成残疾的第三大因素
调整生命年虽然补液可以解决腹泻的急性后果,但没有干预措施
对于腹泻恢复期,在此期间,儿童营养不良的风险很高,下呼吸道
感染和反复腹泻发作。采取安全有效的干预措施,
因此,迫切需要消除疟疾的后果。
乳铁蛋白和溶菌酶是乳源性营养补充剂,可能会减少腹泻的持续时间
发作,治疗或预防潜在的肠道感染,改善肠道功能,并加速营养
复苏然而,目前尚不清楚它们的抗菌作用是否会转化为显著的
改善儿童腹泻的长期临床和营养结果。我们提出一个阶乘,
一项双盲、安慰剂对照、随机试验,旨在确定乳铁蛋白和
补充溶菌酶在减少腹泻发生率和促进营养恢复方面的作用
正在从腹泻和消瘦中恢复的儿童。已出院的6-24个月的肯尼亚儿童
因腹泻住院或门诊,上臂中围[MUAC] <12.5
CM将被随机分配至16周的乳铁蛋白、溶菌酶、两者的组合或安慰剂。本试验将
从最有可能从中受益的人群中提供了大量的疗效、机制和可行性数据,
干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patricia Pavlinac其他文献
Patricia Pavlinac的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patricia Pavlinac', 18)}}的其他基金
Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition
乳铁蛋白和溶菌酶促进营养、临床和肠道恢复:针对腹泻和营养不良儿童的阶乘安慰剂对照随机试验
- 批准号:
10533817 - 财政年份:2021
- 资助金额:
$ 67.09万 - 项目类别:
Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition
乳铁蛋白和溶菌酶促进营养、临床和肠道恢复:针对腹泻和营养不良儿童的阶乘安慰剂对照随机试验
- 批准号:
10322136 - 财政年份:2021
- 资助金额:
$ 67.09万 - 项目类别:
The role of enteric pathogens and antimicrobial resistance in driving clinical and nutritional deterioration, and azithromycin's potential effect, among children discharged from hospital in Kenya
肠道病原体和抗菌药物耐药性在导致肯尼亚出院儿童临床和营养恶化中的作用以及阿奇霉素的潜在影响
- 批准号:
10341184 - 财政年份:2020
- 资助金额:
$ 67.09万 - 项目类别:
The role of enteric pathogens and antimicrobial resistance in driving clinical and nutritional deterioration, and azithromycin's potential effect, among children discharged from hospital in Kenya
肠道病原体和抗菌药物耐药性在导致肯尼亚出院儿童临床和营养恶化中的作用以及阿奇霉素的潜在影响
- 批准号:
10875843 - 财政年份:2020
- 资助金额:
$ 67.09万 - 项目类别:
The role of enteric pathogens and antimicrobial resistance in driving clinical and nutritional deterioration, and azithromycin's potential effect, among children discharged from hospital in Kenya
肠道病原体和抗菌药物耐药性在导致肯尼亚出院儿童临床和营养恶化中的作用以及阿奇霉素的潜在影响
- 批准号:
10569512 - 财政年份:2020
- 资助金额:
$ 67.09万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 67.09万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 67.09万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 67.09万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 67.09万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 67.09万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 67.09万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 67.09万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 67.09万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 67.09万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 67.09万 - 项目类别: